1 min listen
Gut microbiota and outcomes in DLBCL, NFIA-ETO2 fusion cooperates with TP53 in leukemogenesis, and the impact of nirmatrelvir + ritonavir on CLL patie…
FromBlood Podcast
Gut microbiota and outcomes in DLBCL, NFIA-ETO2 fusion cooperates with TP53 in leukemogenesis, and the impact of nirmatrelvir + ritonavir on CLL patie…
FromBlood Podcast
ratings:
Length:
19 minutes
Released:
May 4, 2023
Format:
Podcast episode
Description
In this week’s episode we'll review imbalances in gut microbiota may impact the efficacy and safety of immunochemotherapy in patients with diffuse large B-cell lymphoma. Next, the NFIA-ETO2 fusion, found exclusively in pediatric patients with pure erythroid leukemia, impairs the normal process of erythroid differentiation. Finally, we'll look at the effectiveness of nirmatrelvir plus ritonavir in patients with CLL infected with SARS-CoV-2 during the Omicron surge.
Released:
May 4, 2023
Format:
Podcast episode
Titles in the series (100)
Blood Podcast - Trailer: This is a trailer for the Blood Podcast, a podcast series that will provide timely information about research published in Blood, the most cited peer-reviewed publication in the field of hematology. Each episode will provide a summary of recent Blood arti by Blood Podcast